Differences

This shows you the differences between two versions of the page.

--- resources:research:leads [2025/02/11 14:13] – [SOMA Scans] admin
+++ resources:research:leads [2025/02/18 19:56] (current) – [MDA5] admin
@@ Line 1: / Line 1: @@
-====== SOMA Scans ======
+===== MDA5 =====
+  * **Kyoto University group**
+    * famous for [[https://doi.org/10.1002/art.41105 | pred + tacro + CYC for RP-ILD a/w MDA5]]
+    * important names:
+      * Ran Nakashima
+      * Tsuneyo Mimori
+  * **Chiba University**
+    * [[https://doi.org/10.1136/rmdopen-2022-002795 | Tofacitinib for refractory MDA5]]
+====== FAPi Scans ======
-allows measurement of 11,000 proteins from 55 $\mu L$ sample
+  * [[https://doi.org/10.1148/radiol.220749 | Review: FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease]]
+  * [[https://doi.org/10.1038/s44303-024-00053-z | Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)]]
+  * [[https://doi.org/10.1007/s00259-023-06564-y | Initial results with [$^{18}$F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis]]
+  * [[https://doi.org/10.2967/jnumed.121.261925 | Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study]]
+  * [[https://doi.org/10.1016/s2665-9913(20)30421-5 | FAPI in SSC-ILD]]
+  * [[https://doi.org/10.1164/rccm.202110-2414oc | Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases]]
-  * [[https://somalogic.com/somascan-platform/ | SomaScan Site]]
+====== SOMA Scans ======
+[[https://somalogic.com/somascan-platform/ | SomaScan Site]]
-<todo>[[https://doi.org/10.1101/2024.07.11.24310161]]</todo>
+allows measurement of 11,000 proteins from 55 $\mu L$ sample
-<todo>[[http://doi.org/10.1021/acs.jproteome.4c00411]]</todo>
-<todo>[[https://doi.org/10.1038/s41586-023-06563-x | Nature, Large-scale plasma proteomics comparisons through genetics and disease associations]]</todo>
+  * [[https://doi.org/10.1164/rccm.202109-2106OC | SomaScan in PAH]]
+  * [[https://doi.org/10.1101/2024.07.11.24310161]]
+  * [[http://doi.org/10.1021/acs.jproteome.4c00411]]
+  * [[https://doi.org/10.1038/s41586-023-06563-x | Nature, Large-scale plasma proteomics comparisons through genetics and disease associations]]

ewrobbins.com

User Tools

Site Tools

Differences

Page Tools